Turnstone Biologics Corp. Retained Earnings
Turnstone Biologics Corp. had Retained Earnings of -$264.89 million as of 2025-06-30, per its 10-Q filed 2025-08-08.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2025-08-08
- 2025-06-30: Retained Earnings (Accumulated Deficit) -$264.89M.
- 2025-03-31: Retained Earnings (Accumulated Deficit) -$259.40M.
- 2024-12-31: Retained Earnings (Accumulated Deficit) -$247.59M.
- 2024-09-30: Retained Earnings (Accumulated Deficit) -$234.72M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2025-06-30 | -$264.89M 10-Q · filed 2025-08-08 |
| 2025-03-31 | -$259.40M 10-Q · filed 2025-05-09 |
| 2024-12-31 | -$247.59M 10-Q · filed 2025-08-08 |
| 2024-09-30 | -$234.72M 10-Q · filed 2024-11-12 |
| 2024-06-30 | -$217.69M 10-Q · filed 2024-08-14 |
| 2024-03-31 | -$196.39M 10-Q · filed 2024-05-13 |
| 2023-12-31 | -$176.76M 10-K · filed 2025-03-31 |
| 2023-09-30 | -$160.31M 10-Q · filed 2023-11-13 |
| 2023-06-30 | -$142.99M 10-Q · filed 2023-09-01 |
| 2022-12-31 | -$121.56M 10-K · filed 2024-03-22 |